Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Cutcliffe

Colleen Cutcliffe, Menlo Park, CA US

Patent application numberDescriptionPublished
20120034602Recombinant Polymerases For Improved Single Molecule Sequencing - Provided are compositions comprising recombinant DNA polymerases that include amino acid substitutions, insertions, deletions, and/or exogenous features that confer modified properties upon the polymerase for enhanced single molecule sequencing. Such properties can include enhanced metal ion coordination, reduced exonuclease activity, reduced reaction rates at one or more steps of the polymerase kinetic cycle, decreased branching fraction, altered cofactor selectivity, increased yield, increased thermostability, increased accuracy, increased speed, increased readlength, and the like. Also provided are nucleic acids which encode the polymerases with the aforementioned phenotypes, as well as methods of using such polymerases to make a DNA or to sequence a DNA template.02-09-2012

Colleen Tsui Cutcliffe, San Francisco, CA US

Patent application numberDescriptionPublished
20090023178Parkin Substrate and Assay - The invention provides in vitro, ex vivo, and in vivo assays for Parkin activity, in which Parkin-mediated ubiquitination of a Sept4 protein is measured. The assays may be used to screen for agents that modulate Parkin protein ligase activity.01-22-2009

Colleen Tsui Cutcliffe, Menlo Park, CA US

Patent application numberDescriptionPublished
20120083003PARKIN SUBSTRATE AND ASSAY - The invention provides in vitro, ex vivo, and in vivo assays for Parkin activity, in which Parkin-mediated ubiquitination of a Sept4 protein is measured. The assays may be used to screen for agents that modulate Parkin protein ligase activity.04-05-2012

Graham Stephen Cutcliffe, Caringbah AU

Patent application numberDescriptionPublished
20110174308PRESSURE CONTROL IN RESPIRATORY TREATMENT APPARATUS - An over-pressure control device prevents over-pressure conditions during the delivery of pressure treatment therapy to a patient with a respiratory treatment apparatus. The device may prevent delivered pressure from exceeding a first maximum pressure threshold. The device may also prevent the delivered pressure from exceeding a second maximum pressure threshold when the delivered pressure exceeds another pressure threshold for a period of time. In some embodiments, the second maximum pressure threshold may be lower than the first maximum pressure threshold. In an example embodiment, a set of comparators are configured to compare pressure with a maximum pressure threshold and to control a reduction in the pressure if the pressure exceeds the maximum pressure threshold. The set may also be configured to compare the pressure with a pressure threshold and to control reduction in the maximum pressure threshold if the pressure exceeds the pressure threshold for a period of time.07-21-2011